Airway Management Devices Market Size, Share, Growth, and Industry Analysis, By Type (Endotracheal tubes,Laryngeal mask airway), By Application (Non-emergency surgery,ICU/emergency room,Others), Regional Insights and Forecast to 2035

Airway Management Devices Market Overview

The global Airway Management Devices Market is forecast to expand from USD 2313.29 million in 2026 to USD 2414.84 million in 2027, and is expected to reach USD 3404.92 million by 2035, growing at a CAGR of 4.39% over the forecast period.

The global Airway Management Devices market is projected to reach 42.7 million units in annual demand by 2025, with adoption in surgical, emergency, and intensive care settings driving demand. High utilization rates are recorded in perioperative environments, where airway control is required in over 90% of procedures involving general anesthesia. The market’s expansion is also supported by the rising incidence of respiratory conditions, with chronic obstructive pulmonary disease (COPD) affecting over 384 million people worldwide. Hospitals account for more than 70% of total device usage, while ambulatory surgical centers and emergency medical services are rapidly increasing procurement volumes.

In the United States, airway management devices are used in over 21 million surgical cases annually, representing more than 45% of the North American market by unit volume. The US has approximately 6,100 registered hospitals, of which over 5,800 maintain advanced airway equipment inventories for ICU and surgical suites. With an aging population—54 million Americans over 65 years old—the demand for airway devices in both elective and emergency care is steadily increasing. Pre-hospital usage by emergency medical services accounts for more than 2.5 million device applications annually in the country.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 68% of hospitals report increased demand for advanced airway devices due to rising surgical volumes and respiratory emergency cases.
• Major Market Restraint: 41% of procurement teams cite device cost as a primary barrier to upgrading to advanced airway systems.
• Emerging Trends: 55% growth in adoption of video laryngoscopes among high-acuity care centers.
• Regional Leadership: 47% of global market share concentrated in North America, with the US as the dominant country.
• Competitive Landscape: Top five manufacturers control 62% of the market’s total unit sales.
• Market Segmentation: 58% of demand generated by endotracheal tubes, followed by 42% from laryngeal mask airway products.
• Recent Development: 36% of new product launches focus on disposable and single-use airway devices.

Airway Management Devices Market Latest Trends

The Airway Management Devices market is seeing rapid product innovation, with more than 140 new models introduced globally between 2020 and 2024. Disposable device demand has surged, representing 39% of total sales in 2025 due to heightened infection control protocols. Video-enabled airway systems now account for over 27% of laryngoscope sales, driven by enhanced visualization requirements during complex intubations. Integration with patient monitoring systems is another significant trend, as 33% of new products include real-time oxygenation feedback features. Furthermore, pediatric-specific airway devices are gaining ground, with over 6.3 million units annually addressing specialized neonatal and pediatric care needs.

Airway Management Devices Market Dynamics

DRIVER

"Rising surgical and emergency care volumes"

Global surgical procedure volumes exceed 320 million annually, with more than 40% requiring airway management. Growth in trauma cases—over 4.4 million deaths annually—also pushes demand for rapid airway access solutions. The increase in global ICU bed capacity, now exceeding 1.9 million beds, has significantly expanded the installed base of airway devices.

RESTRAINT

"High cost and limited reimbursement in some regions"

More than 41% of healthcare facilities in low- and middle-income countries delay equipment upgrades due to procurement budgets. Inconsistent reimbursement policies result in slower adoption rates, particularly for advanced video laryngoscopes, which can cost up to 5 times more than traditional models.

OPPORTUNITY

"Expansion of pre-hospital and home care airway solutions"

The number of trained paramedics globally now exceeds 6.8 million, with pre-hospital intubations increasing by 21% over the past five years. Portable, battery-powered airway devices are expanding use cases in rural and resource-limited areas, creating a large untapped market.

CHALLENGE

"Device-associated infection and safety concerns"

Airway devices are linked to 15% of hospital-acquired pneumonia cases in ventilated patients. Reusable devices require complex sterilization, and non-compliance with disinfection standards remains high—over 22% of facilities report lapses in reprocessing protocols.

Airway Management Devices Market Segmentation

The market is segmented by type and application, with distinct usage patterns across clinical settings.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Endotracheal tubes: Endotracheal tubes account for 58% of global unit sales, with over 24.7 million units used in 2025. They are the standard for securing airways in major surgeries, ICU ventilation, and emergency care, providing reliable oxygenation and airway protection in high-risk patients.

The Endotracheal tubes segment in the global Airway Management Devices market is projected at USD 1,305.28 million in 2025, holding 58.9% market share, and expected to grow to USD 1,924.92 million by 2034 at a CAGR of 4.32%.

Top 5 Major Dominant Countries in the Endotracheal tubes Segment

• United States: USD 520.12 million in 2025, 39.85% share, 4.30% CAGR, driven by over 35 million annual surgical procedures and advanced ICU capacity exceeding 955,000 beds.
• China: USD 196.36 million in 2025, 15.04% share, 4.78% CAGR, supported by 70+ million surgeries annually and rising trauma care demand.
• Germany: USD 117.47 million in 2025, 9% share, 4.15% CAGR, influenced by over 2,000 acute care hospitals and strict anesthesia protocols.
• Japan: USD 104.42 million in 2025, 8% share, 4.05% CAGR, driven by an aging population and advanced perioperative care systems.
• India: USD 78.31 million in 2025, 6% share, 4.92% CAGR, supported by growing tertiary hospital networks and medical tourism.

Laryngeal mask airway: Laryngeal mask airways represent 42% of global demand, with 17.9 million units used in 2025. Their ease of insertion and lower complication rates make them preferred in elective surgeries and short-duration anesthesia cases.

The Laryngeal mask airway segment is estimated at USD 910.72 million in 2025, capturing 41.1% share of the global market, and is set to reach USD 1,336.81 million by 2034, registering a CAGR of 4.49%.

Top 5 Major Dominant Countries in the Laryngeal mask airway Segment

• United States: USD 364.28 million in 2025, 40% share, 4.40% CAGR, with 45% of all airway procedures preferring laryngeal masks for elective surgeries.
• United Kingdom: USD 91.07 million in 2025, 10% share, 4.35% CAGR, supported by NHS adoption of single-use airway devices to reduce infection risks.
• China: USD 81.96 million in 2025, 9% share, 4.70% CAGR, driven by increased use in outpatient and day-care surgeries.
• Australia: USD 63.75 million in 2025, 7% share, 4.55% CAGR, driven by strong private hospital penetration and high anesthesia procedure rates.
• Germany: USD 54.64 million in 2025, 6% share, 4.20% CAGR, with 48% adoption in anesthesia practices across major hospitals.

BY APPLICATION

Non-emergency surgery: Non-emergency surgical procedures account for 53% of airway device use, representing over 22.6 million devices in 2025. Common in elective orthopedic, cardiac, and ENT surgeries, these devices are critical for anesthesia delivery.

Non-emergency surgery applications are projected at USD 1,219.92 million in 2025, holding 55% share of the global market, and forecast to grow to USD 1,790.56 million by 2034 at a CAGR of 4.36%.

Top 5 Major Dominant Countries in the Non-emergency surgery Application

• United States: USD 487.96 million in 2025, 40% share, 4.35% CAGR, with 60% of procedures under general anesthesia requiring airway devices.
• Germany: USD 134.19 million in 2025, 11% share, 4.18% CAGR, influenced by high surgical volumes in public hospitals.
• Japan: USD 109.79 million in 2025, 9% share, 4.05% CAGR, driven by advanced perioperative care in aging demographics.
• China: USD 97.59 million in 2025, 8% share, 4.65% CAGR, driven by expansion of day-care surgical centers.
• United Kingdom: USD 85.39 million in 2025, 7% share, 4.25% CAGR, supported by NHS emphasis on elective surgeries.

ICU/emergency room: ICU and ER settings consume 34% of airway devices, with 14.5 million units deployed annually. High-acuity cases, including severe trauma, respiratory failure, and cardiac arrest, drive demand.

ICU/emergency room applications are valued at USD 775.60 million in 2025, making up 35% share, and projected to reach USD 1,137.74 million by 2034 at a CAGR of 4.38%.

Top 5 Major Dominant Countries in the ICU/emergency room Application

• United States: USD 279.21 million in 2025, 36% share, 4.30% CAGR, driven by 955,000+ ICU beds nationwide.
• China: USD 139.60 million in 2025, 18% share, 4.68% CAGR, supported by increasing emergency care investments.
• India: USD 93.07 million in 2025, 12% share, 4.85% CAGR, influenced by expanding trauma care facilities.
• Brazil: USD 69.80 million in 2025, 9% share, 4.40% CAGR, with rapid ICU upgrades in metropolitan hospitals.
• Germany: USD 62.05 million in 2025, 8% share, 4.15% CAGR, supported by advanced emergency medicine infrastructure.

Others: Other applications, including outpatient surgery centers and home care settings, represent 13% of demand, with 5.6 million units used, particularly for chronic respiratory patients requiring temporary airway support.

Other applications, including pre-hospital care and military medicine, are valued at USD 220.48 million in 2025, representing 10% share, and set to rise to USD 333.43 million by 2034 at a CAGR of 4.50%.

Top 5 Major Dominant Countries in the Others Application

• United States: USD 66.14 million in 2025, 30% share, 4.45% CAGR, driven by EMS integration in airway protocols.
• Australia: USD 28.66 million in 2025, 13% share, 4.50% CAGR, supported by widespread rural emergency response systems.
• Canada: USD 26.45 million in 2025, 12% share, 4.40% CAGR, benefiting from national paramedic training programs.
• United Kingdom: USD 22.04 million in 2025, 10% share, 4.35% CAGR, with increased adoption in ambulance services.
• Japan: USD 20.66 million in 2025, 9% share, 4.30% CAGR, with strong adoption in disaster response readiness.

Airway Management Devices Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America accounts for 47% of the global airway management devices market in 2025, representing approximately 20.1 million units in annual demand. The United States leads the region with 14.5 million units, holding 72% of the North American share, driven by its advanced surgical infrastructure and high ICU bed availability exceeding 955,000.

North America is valued at USD 1,040.00 million in 2025, holding 46.9% global share, and projected to reach USD 1,520.36 million by 2034 at a CAGR of 4.34%, driven by high surgical volumes and ICU capacity.

North America - Major Dominant Countries in the Airway Management Devices Market

• United States: USD 780.80 million in 2025, 75% share, 4.32% CAGR, leading global demand with 35+ million annual surgeries.
• Canada: USD 156.00 million in 2025, 15% share, 4.38% CAGR, supported by national healthcare procurement systems.
• Mexico: USD 62.40 million in 2025, 6% share, 4.40% CAGR, expanding adoption in private hospital networks.
• Puerto Rico: USD 20.80 million in 2025, 2% share, 4.35% CAGR, with modernizing hospital infrastructure.
• Dominican Republic: USD 20.00 million in 2025, 2% share, 4.30% CAGR, supported by medical tourism

Europe

Europe holds 29% of the global market, equivalent to 12.4 million airway device units in 2025. Germany leads with 2.6 million units (21% of regional demand), fueled by its 2,000+ acute care hospitals and over 25 million annual surgical procedures. The UK follows with 2.1 million units (17% share), supported by National Health Service (NHS) adoption of single-use devices to reduce hospital-acquired infection risks.

Europe holds USD 643.00 million in 2025, capturing 29% market share, and is expected to grow to USD 945.19 million by 2034 at a CAGR of 4.32%, led by advanced surgical infrastructure.

Europe - Major Dominant Countries in the Airway Management Devices Market

• Germany: USD 135.03 million in 2025, 21% share, 4.15% CAGR, with 2,000+ acute care hospitals.
• United Kingdom: USD 109.31 million in 2025, 17% share, 4.28% CAGR, adopting disposable devices in NHS.
• France: USD 96.45 million in 2025, 15% share, 4.30% CAGR, driven by high anesthesia volumes.
• Italy: USD 83.59 million in 2025, 13% share, 4.25% CAGR, benefiting from increased operating room capacity.
• Spain: USD 64.30 million in 2025, 10% share, 4.22% CAGR, supported by modernization of emergency departments.

Asia-Pacific

Asia-Pacific represents 19% of the global airway management devices market, with approximately 8.1 million units in 2025. China dominates the region with 3.1 million units (38% share), driven by large-scale hospital expansions and more than 70 million annual surgeries. Japan follows with 1.7 million units (21% share), benefiting from an advanced healthcare system and high aging population.

Asia is valued at USD 421.04 million in 2025, accounting for 19% global share, and will reach USD 624.37 million by 2034 at a CAGR of 4.45%, driven by rising surgeries and trauma care demand.

Asia - Major Dominant Countries in the Airway Management Devices Market

• China: USD 159.99 million in 2025, 38% share, 4.68% CAGR, with 70+ million surgeries annually.
• Japan: USD 88.42 million in 2025, 21% share, 4.05% CAGR, high adoption in elderly care.
• India: USD 67.37 million in 2025, 16% share, 4.92% CAGR, growing tertiary hospital capacity.
• South Korea: USD 50.52 million in 2025, 12% share, 4.35% CAGR, with strong ICU penetration.
• Australia: USD 50.52 million in 2025, 12% share, 4.55% CAGR, advanced private healthcare demand.

Middle East & Africa

The Middle East & Africa market accounts for 5% of global demand, representing 2.1 million airway device units in 2025. Saudi Arabia leads with 620,000 units (30% share), driven by expanding ICU capacity in major cities like Riyadh and Jeddah. South Africa follows with 480,000 units (23% share), benefiting from advanced private healthcare networks and growing adoption in government hospitals.

Middle East & Africa totals USD 111.96 million in 2025, holding 5% share, and projected to reach USD 171.81 million by 2034 at a CAGR of 4.64%, led by ICU expansion projects.

Middle East and Africa - Major Dominant Countries in the Airway Management Devices Market

• Saudi Arabia: USD 33.59 million in 2025, 30% share, 4.65% CAGR, expanding tertiary hospitals.
• South Africa: USD 25.75 million in 2025, 23% share, 4.55% CAGR, advanced private sector adoption.
• UAE: USD 19.03 million in 2025, 17% share, 4.60% CAGR, growing medical tourism.
• Egypt: USD 17.91 million in 2025, 16% share, 4.50% CAGR, with modernizing ICU facilities.
• Nigeria: USD 15.68 million in 2025, 14% share, 4.70% CAGR, emergency service expansion.

List of Top Airway Management Devices Companies

• Jiangxi Saixin Medical Technology Co., Ltd.
• Smiths Medical
• Guangzhou Weili Medical Devices Co., Ltd.
• Ambu
• Medtronic
• Zhejiang Haisheng Medical Instrument Co., Ltd.
• Shenzhen Insides Medical Technology Co., Ltd.
• Zhejiang Youyi Medical Devices Co., Ltd.

Top Two Companies With Highest Share

• Medtronic controls 18% of the global market, driven by a broad product portfolio and hospital contracts in over 140 countries. Smiths Medical holds 15% share, with strong sales in Europe and North America.

Investment Analysis and Opportunities

The airway management devices market is attracting significant capital investments, with over USD 420 million in manufacturing capacity expansions announced since 2022. Emerging economies account for 34% of planned investments, targeting infrastructure upgrades in surgical and emergency care. Large hospital groups are committing to multi-year procurement contracts, securing up to 1 million units annually for integrated health networks. The trend towards single-use devices presents a $250 million annual opportunity, particularly in markets with strict infection control standards. Strategic partnerships between device makers and telehealth providers are expected to create hybrid airway monitoring solutions for home-based chronic care.

New Product Development

Between 2020 and 2024, manufacturers launched over 140 new airway devices, with 46% designed for single-use. Video-enabled intubation systems have grown from 15% to 27% of product launches. Pediatric airway devices, once representing only 8% of new releases, now account for 14%, reflecting the growing focus on specialized care. Battery-powered portable airway devices have been introduced for field and military medicine, with runtime improvements from 2 hours to over 6 hours per charge. Integration with AI-assisted intubation guidance systems is emerging, offering real-time anatomical mapping to reduce failed airway attempts.

Five Recent Developments

• Medtronic introduced a single-use video laryngoscope model in 2024, with 20% lower weight and integrated suction capabilities.
• Ambu expanded its disposable airway device line in 2023, reaching 40 million annual unit capacity.
• Smiths Medical launched a pediatric airway visualization system in 2024, now adopted in 1,200 hospitals.
• Guangzhou Weili Medical Devices added a high-flow oxygen delivery feature to its airway kits in 2023.
• Zhejiang Haisheng Medical Instrument Co. completed a manufacturing expansion in 2024, boosting output by 30%.

Report Coverage of Airway Management Devices Market

This Airway Management Devices Market Report provides comprehensive coverage of global, regional, and country-level market metrics, including unit sales, market share distribution, and product category growth. The analysis spans hospital, ICU, surgical, and pre-hospital care applications, segmented by device type and use case. It also evaluates competitive strategies of leading manufacturers, highlighting market share leadership, product innovations, and distribution network strengths. Regional assessments detail adoption rates, procurement volumes, and healthcare infrastructure impacts on device demand. The report further examines investment flows, merger and acquisition activities, and emerging opportunities in disposable and video-assisted airway systems.

Airway Management Devices Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 2313.29 Million in 2026
Market Size Value By	USD 3404.92 Million by 2035
Growth Rate	CAGR of 4.39% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Endotracheal tubes Laryngeal mask airway By Application : Non-emergency surgery ICU/emergency room Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample